trypan blue solution (HiMedia Laboratories)
90
Structured Review
HiMedia Laboratories
trypan blue solution
Trypan Blue Solution, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trypan+blue+solution/trypan+blue+solution/pmc04026434-79-16-20
Average 90 stars, based on 1 article reviews
Trypan Blue Solution, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trypan+blue+solution/trypan+blue+solution/pmc04026434-79-16-20
Average 90 stars, based on 1 article reviews
trypan blue solution - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
MTT Assay:Article Title: Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer. Article Snippet: Combining photothermal and chemotherapy is an emerging strategy for tumor irradiation in a minimally invasive manner, utilizing photothermal transduction agents and anticancer drugs.. The present work developed a 2D carbon nanomaterial graphene oxide (GO)-based nanoplatform that converted to 3D colloidal spherical structures upon functionalization with an amphiphilic polymer mPEG-PLA (1, 0.5/1/2) and entrapped doxorubicin (Dox) physically.. The Dox@GO(mPP) (1/0.5) NPs displayed the least particle size (161 nm), the highest stability with no aggregation, the highest Dox loading (6.3 %) and encapsulation efficiency (70 %). Article Title: ct-DNA compaction by nanoparticles formed by silica and gemini surfactants having hydroxyl group substituted spacers: In vitro, in vivo, and ex vivo gene uptake to cancer cells. Article Snippet: Hybrid nanoparticles formed by Silica (SiO2) coated with cationic gemini surfactants with variable hydroxyl group substituted spacers, 12-4(OH)-12,2Br and 12-4(OH)2-12,2Br have shown a great extent of compaction of calf thymus DNA (ct-DNA) compared to conventional counterpart cationic surfactant, dodecyl trimethylammonium bromide (DTAB).. Study shows not only the hydrophobicity of the spacer but also the hydrogen bonding interactions between the hydroxyl group substituted spacer and DNA have a great role in DNA compaction.. 12-4(OH)2-12,2Br is more efficient in compacting ct-DNA compared to 12-4(OH)-12,2Br due to the stronger binding of the former with ct-DNA than the latter. Article Title: Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer. Article Snippet: Nanomedicines have emerged as a potential strategy to reduce the toxic effect of drugs administered via conventional approaches.. Nanomedicines undergo passive and active targeting of the tumor tissues, thereby causing localized drug delivery and reducing drug demand and side effects.. Here, we prepared reduction-sensitive oxaliplatin-conjugated human serum albumin nanoparticles with a small size, uniform surfaces, and a satisfactory encapsulation coefficient. Purification:Article Title: Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer. Article Snippet: Combining photothermal and chemotherapy is an emerging strategy for tumor irradiation in a minimally invasive manner, utilizing photothermal transduction agents and anticancer drugs.. The present work developed a 2D carbon nanomaterial graphene oxide (GO)-based nanoplatform that converted to 3D colloidal spherical structures upon functionalization with an amphiphilic polymer mPEG-PLA (1, 0.5/1/2) and entrapped doxorubicin (Dox) physically.. The Dox@GO(mPP) (1/0.5) NPs displayed the least particle size (161 nm), the highest stability with no aggregation, the highest Dox loading (6.3 %) and encapsulation efficiency (70 %). Suspension:Article Title: Synergistic role of Mycobacterium indicus pranii and human beta Defensin-2 as adjunctive therapy against Mycobacterium tuberculosis. Article Snippet: Host-directed therapies (HDT) via modulation of specific host responses like inflammation can limit mycobacterial infection.. HDTs could be included in current TB therapy as an adjunct to increase bacterial clearance and limit tissue damage to control spread.. Individually, Mycobacterium indicus pranii (MIP) and human beta defensin2 (hBD-2) are promising therapies for tuberculosis (TB). other:Article Title: Cryopreservation of human lung adenocarcinoma spheroids using MMC based cryomixtures. Article Snippet: Cryopreservation remains crucial bottleneck for storing and transporting bioengineered 3D cell models, vital for preclinical drug development and cancer research.. Conventional cryoprotectants like fetal bovine serum (FBS) and dimethyl sulfoxide (DMSO) present cytotoxicity challenges and lack efficacy in maintaining structural integrity and viability in complex 3D culture models.. This study investigates the efficacy of two carbohydrate-based macromolecular crowders (MMCs), polydextrose III (PD) and resistant maltodextrin (rMD), in cryopreserving human lung adenocarcinoma spheroids as alternatives to FBS. Article Title: Generation of FECD Phenotypes in the Mouse Cornea by UVA Exposure and Surgical Removal of its Corneal Endothelial Layer Article Snippet: Article Title: Block HPMA-based pH-sensitive gemcitabine pro-drug nanoaggregates for cancer treatment Article Snippet: A pH-sensitive, methoxy(polyethylene glycol)(hydrazone)block(hydroxypropyl methacrylamide), covalently linked to gemcitabine (mP(Hz)-bH(GEM)), was developed, which formed spherical nanoaggregates in the aqueous environment.. The conjugate/nanoaggregates (NA) were physicochemically characterized using DLS, 1H NMR, FTIR, GPC, SAXS, MALDI-TOF, pH-dependent drug release, and hemolysis studies.. Human HR+/cells, MCF-7 and MDA-MB-231 were used to investigate the NA’s therapeutic effectiveness in vitro via cytotoxicity, DNA fragmentation, cellular uptake, cell cycle assays, nuclear staining, and immunoblot analysis. |